Trigeminal Neuralgia Treatment Market to Witness Huge Growth by...

Trigeminal Neuralgia Treatment Market to Witness Huge Growth by 2028

Posted 2023-04-21 11:52:24

Medication is often the first line of Trigeminal Neuralgia Treatment Market. Anticonvulsants such as carbamazepine and gabapentin are commonly prescribed to reduce the frequency and intensity of the pain. These medications work by reducing the sensitivity of the nerves and decreasing the firing of the trigeminal nerve. Muscle relaxants such as baclofen can also be prescribed to relieve the muscle spasms that can trigger the pain. If medication does not provide relief, surgery may be recommended. The goal of surgery is to relieve the pressure on the trigeminal nerve and reduce the frequency and intensity of the pain. There are several surgical options available, including:

MVD is a surgical procedure that involves moving the blood vessels that are pressing on the trigeminal nerve. This procedure is performed under general anesthesia and requires a small incision behind the ear. A small pad is placed between the nerve and the blood vessel to relieve the pressure on the nerve. MVD is a highly effective treatment option for Trigeminal Neuralgia, with a success rate of up to 80%.